Japanese drugmaker Takeda has suspended dosing in phase 2 trials of its orexin agonist TAK-994, saying it had encountered a "safety signal" in the study. The future of the programme seems to be in ...

Role of spontaneous and sensory orexin neuron dynamics in rapid locomotion initiation. Progress in Neurobiology, 187: 101771 Kosse C, Burdakov D (2019) Natural hypothalamic circuit dynamics underlying ...